Bao Q, Kumar A, Wu D, Zhou J
Drug Discov Today. 2024; 29(6):103986.
PMID: 38642703
PMC: 11416859.
DOI: 10.1016/j.drudis.2024.103986.
Ju J, Zhang H, Guan S, Liu C, Du J, Shen X
Molecules. 2023; 28(24).
PMID: 38138487
PMC: 10745707.
DOI: 10.3390/molecules28247997.
Imtiaz S, Ahmad War J, Banoo S, Khan S
RSC Adv. 2022; 11(19):11083-11165.
PMID: 35423648
PMC: 8695948.
DOI: 10.1039/d1ra00392e.
Liu K, Zhu K, Zhang H
RSC Med Chem. 2022; 13(1):39-53.
PMID: 35224495
PMC: 8792826.
DOI: 10.1039/d1md00274k.
Sim J, Lanka S, Jo J, Chaudhary C, Vishwanath M, Jung C
Pharmaceuticals (Basel). 2021; 14(11).
PMID: 34832958
PMC: 8622415.
DOI: 10.3390/ph14111176.
Polycomb group proteins in cancer: multifaceted functions and strategies for modulation.
Wang S, Ordonez-Rubiano S, Dhiman A, Jiao G, Strohmier B, Krusemark C
NAR Cancer. 2021; 3(4):zcab039.
PMID: 34617019
PMC: 8489530.
DOI: 10.1093/narcan/zcab039.
Discovery of EEDi-5273 as an Exceptionally Potent and Orally Efficacious EED Inhibitor Capable of Achieving Complete and Persistent Tumor Regression.
Rej R, Wang C, Lu J, Wang M, Petrunak E, Zawacki K
J Med Chem. 2021; 64(19):14540-14556.
PMID: 34613724
PMC: 8862192.
DOI: 10.1021/acs.jmedchem.1c01059.
Polycomb Repressive Complex 2 Modulation through the Development of EZH2-EED Interaction Inhibitors and EED Binders.
Tomassi S, Romanelli A, Zwergel C, Valente S, Mai A
J Med Chem. 2021; 64(16):11774-11797.
PMID: 34351144
PMC: 8404197.
DOI: 10.1021/acs.jmedchem.1c00226.
The control of polycomb repressive complexes by long noncoding RNAs.
Trotman J, Braceros K, Cherney R, Murvin M, Calabrese J
Wiley Interdiscip Rev RNA. 2021; 12(6):e1657.
PMID: 33861025
PMC: 8500928.
DOI: 10.1002/wrna.1657.
EEDi-5285: An Exceptionally Potent, Efficacious, and Orally Active Small-Molecule Inhibitor of Embryonic Ectoderm Development.
Rej R, Wang C, Lu J, Wang M, Petrunak E, Zawacki K
J Med Chem. 2020; 63(13):7252-7267.
PMID: 32580550
PMC: 8859984.
DOI: 10.1021/acs.jmedchem.0c00479.
The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review.
Rugo H, Jacobs I, Sharma S, Scappaticci F, Paul T, Jensen-Pergakes K
Adv Ther. 2020; 37(7):3059-3082.
PMID: 32445185
PMC: 7467409.
DOI: 10.1007/s12325-020-01379-x.
Design and Construction of a Focused DNA-Encoded Library for Multivalent Chromatin Reader Proteins.
Rectenwald J, Guduru S, Dang Z, Collins L, Liao Y, Norris-Drouin J
Molecules. 2020; 25(4).
PMID: 32098353
PMC: 7070942.
DOI: 10.3390/molecules25040979.
MEP50/PRMT5-mediated methylation activates GLI1 in Hedgehog signalling through inhibition of ubiquitination by the ITCH/NUMB complex.
Abe Y, Suzuki Y, Kawamura K, Tanaka N
Commun Biol. 2019; 2:23.
PMID: 30675521
PMC: 6338668.
DOI: 10.1038/s42003-018-0275-4.
Six Years (2012-2018) of Researches on Catalytic EZH2 Inhibitors: The Boom of the 2-Pyridone Compounds.
Fioravanti R, Stazi G, Zwergel C, Valente S, Mai A
Chem Rec. 2018; 18(12):1818-1832.
PMID: 30338896
PMC: 7410397.
DOI: 10.1002/tcr.201800091.
RNA-modifying proteins as anticancer drug targets.
Boriack-Sjodin P, Ribich S, Copeland R
Nat Rev Drug Discov. 2018; 17(6):435-453.
PMID: 29773918
DOI: 10.1038/nrd.2018.71.
Histone Methyltransferase EZH2: A Therapeutic Target for Ovarian Cancer.
Jones B, Varambally S, Arend R
Mol Cancer Ther. 2018; 17(3):591-602.
PMID: 29726819
PMC: 5939583.
DOI: 10.1158/1535-7163.MCT-17-0437.
Enhancer of zeste homolog 2 (EZH2) inhibitors.
Gulati N, Beguelin W, Giulino-Roth L
Leuk Lymphoma. 2018; 59(7):1574-1585.
PMID: 29473431
PMC: 6659997.
DOI: 10.1080/10428194.2018.1430795.
The Ligand Binding Landscape of Diacylglycerol Kinases.
Franks C, Campbell S, Purow B, Harris T, Hsu K
Cell Chem Biol. 2017; 24(7):870-880.e5.
PMID: 28712745
PMC: 5551460.
DOI: 10.1016/j.chembiol.2017.06.007.
Inhibitors of Protein Methyltransferases and Demethylases.
Umit Kaniskan H, Martini M, Jin J
Chem Rev. 2017; 118(3):989-1068.
PMID: 28338320
PMC: 5610952.
DOI: 10.1021/acs.chemrev.6b00801.
Discovery of Peptidomimetic Ligands of EED as Allosteric Inhibitors of PRC2.
Barnash K, The J, Norris-Drouin J, Cholensky S, Worley B, Li F
ACS Comb Sci. 2017; 19(3):161-172.
PMID: 28165227
PMC: 5376495.
DOI: 10.1021/acscombsci.6b00174.